Recro Pharma, Inc.
REPH
Price:
$2.09
Market Cap:
$116.13M
Recro Pharma, Inc., a contract development and manufacturing organization, engages in the development, manufacturing, and packaging for various therapeutic dosage forms primarily in the small molecule therapeutic development in the United States and internationally. It offers its products in the form of oral solid doses, sterile injectables, oral liquids, tablets, topicals, liquid/powder filled capsules, ophthalmic droppers, liposomes, and nano/microparticles, as well as in the areas of aseptic fill/finish, lyophilization, packaging, and logistics services. The company was formerly known as Recro Pharma I, Inc. and changed its name to Recro Pharma, Inc. in August 2008. Recro Pharma, Inc. was...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2014-03-07
Stock Exchange
NASDAQ
Ticker
REPH
PE Ratio
[-8.04]
ROE
[-15.05%]
Current Ratio
[1.07]
Dividend Yield
[0%]
Enterprise Value
[189.40M]
Dividend History
The PE Ratio as of May 2025 (TTM) for Recro Pharma, Inc. (REPH) is -8.04
According to Recro Pharma, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -8.04. This represents a change of 18.55% compared to the average of -6.78 of the last 4 quarters.
Recro Pharma, Inc. (REPH) Historical PE Ratio (quarterly & annually)
How has REPH PE Ratio performed in the past?
The mean historical PE Ratio of Recro Pharma, Inc. over the last ten years is -0.75. The current -8.04 PE Ratio has changed 106.75% with respect to the historical average. Over the past ten years (40 quarters), REPH's PE Ratio was at its highest in in the June 2021 quarter at 18.26. The PE Ratio was at its lowest in in the June 2019 quarter at -18.28.
Average
-0.75
Median
-2.54
Minimum
-10.69
Maximum
22.59
Recro Pharma, Inc. (REPH) PE Ratio by Quarter and Year
Discovering the peaks and valleys of Recro Pharma, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 555.18%
Maximum Annual PE Ratio = 22.59
Minimum Annual Increase = -2373.68%
Minimum Annual PE Ratio = -10.69
| Year | PE Ratio | Change |
|---|---|---|
| 2023 | -2.51 | -42.03% |
| 2022 | -4.34 | 52.39% |
| 2021 | -2.85 | 96.26% |
| 2020 | -1.45 | -86.43% |
| 2019 | -10.69 | 555.18% |
| 2018 | -1.63 | -47.17% |
| 2017 | -3.09 | 20.46% |
| 2016 | -2.56 | -111.35% |
| 2015 | 22.59 | -2373.68% |
| 2014 | -0.99 | -96.34% |
Recro Pharma, Inc. (REPH) Average PE Ratio
How has REPH PE Ratio performed in the past?
The current PE Ratio of Recro Pharma, Inc. (REPH) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-3.23
5-year avg
-4.37
10-year avg
-0.75
Recro Pharma, Inc. (REPH) PE Ratio vs. Peers
How is REPH’s PE Ratio compared to its peers?
Recro Pharma, Inc.’s PE Ratio is
| Company | PE Ratio | Market cap |
|---|
Build a custom stock screener for Recro Pharma, Inc. (REPH) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Recro Pharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Recro Pharma, Inc. (REPH) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Recro Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the PE Ratio?
How can you use the PE Ratio?
What is Recro Pharma, Inc.'s PE Ratio?
How is the PE Ratio calculated for Recro Pharma, Inc. (REPH)?
What is the highest PE Ratio for Recro Pharma, Inc. (REPH)?
What is the 3-year average PE Ratio for Recro Pharma, Inc. (REPH)?
What is the 5-year average PE Ratio for Recro Pharma, Inc. (REPH)?
How does the current PE Ratio for Recro Pharma, Inc. (REPH) compare to its historical average?